Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Photodynamic Therapy (PDT) Oncology Registry

Trial Profile

Photodynamic Therapy (PDT) Oncology Registry

Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2018

At a glance

  • Drugs Porfimer sodium (Primary)
  • Indications Lung cancer; Oesophageal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Aug 2018 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2024.
    • 08 Jan 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Nov 2018 s reported by ClinicalTrials.gov record.
    • 19 Nov 2014 Planned number of patients changed from 600 to 1000 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top